Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

H1N1 Influenza A Vaccine (Split Virion)，Inactivated

Approval Number

国药准字S20090014

Company北京科兴生物制品有限公司

Registration Date

October 15, 2024

Drug Information

Generic Name

甲型H1N1流感病毒裂解疫苗

Trade Name

盼尔来福.1（PANFLU.1）

Dosage Form

注射剂

Strength

15μg/0.5ml/支(单个人用剂量)。每一次人用剂量为0.5ml，含甲型H1N1流感病毒血凝素抗原15μg。

Drug Type

生物制品

Registration Date

October 15, 2024

Company Information

Applicant Company

Company Name北京科兴生物制品有限公司

Company Address

北京市海淀区上地西路39号

Manufacturing Company

Company Name北京科兴生物制品有限公司

Company Address

北京市海淀区上地西路39号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy